Oramed Pharmaceuticals Current Ratio 2011-2024 | ORMP
Oramed Pharmaceuticals current ratio from 2011 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Oramed Pharmaceuticals Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-12-31 | $0.14B | $0.01B | 25.19 |
| 2024-09-30 | $0.14B | $0.01B | 27.08 |
| 2024-06-30 | $0.15B | $0.00B | 41.06 |
| 2024-03-31 | $0.18B | $0.03B | 5.28 |
| 2023-12-31 | $0.16B | $0.05B | 3.06 |
| 2023-09-30 | $0.18B | $0.08B | 2.25 |
| 2023-06-30 | $0.15B | $0.00B | 141.49 |
| 2023-03-31 | $0.16B | $0.01B | 31.21 |
| 2022-12-31 | $0.16B | $0.01B | 27.34 |
| 2022-09-30 | $0.16B | $0.01B | 24.55 |
| 2022-06-30 | $0.14B | $0.01B | 21.01 |
| 2022-03-31 | $0.14B | $0.01B | 22.70 |
| 2021-12-31 | $0.15B | $0.01B | 20.08 |
| 2021-11-30 | $0.15B | $0.01B | 19.89 |
| 2021-09-30 | $0.00B | 0.00 | |
| 2021-08-31 | $0.10B | $0.01B | 14.27 |
| 2021-06-30 | $0.00B | 0.00 | |
| 2021-05-31 | $0.07B | $0.01B | 12.56 |
| 2021-03-31 | $0.00B | 0.00 | |
| 2021-02-28 | $0.06B | $0.01B | 9.69 |
| 2020-11-30 | $0.04B | $0.01B | 6.27 |
| 2020-08-31 | $0.04B | $0.01B | 8.93 |
| 2020-05-31 | $0.04B | $0.00B | 9.99 |
| 2020-02-29 | $0.03B | $0.01B | 5.72 |
| 2019-11-30 | $0.03B | $0.01B | 6.62 |
| 2019-08-31 | $0.03B | $0.01B | 6.28 |
| 2019-05-31 | $0.03B | $0.01B | 5.10 |
| 2019-02-28 | $0.03B | $0.01B | 5.80 |
| 2018-11-30 | $0.03B | $0.00B | 7.12 |
| 2018-08-31 | $0.03B | $0.01B | 6.82 |
| 2018-05-31 | $0.02B | $0.01B | 4.18 |
| 2018-02-28 | $0.02B | $0.01B | 4.48 |
| 2017-11-30 | $0.02B | $0.01B | 3.73 |
| 2017-08-31 | $0.02B | $0.01B | 3.93 |
| 2017-05-31 | $0.03B | $0.01B | 5.23 |
| 2017-02-28 | $0.03B | $0.01B | 6.04 |
| 2016-11-30 | $0.03B | $0.01B | 6.44 |
| 2016-08-31 | $0.03B | $0.00B | 8.63 |
| 2016-05-31 | $0.03B | $0.00B | 18.79 |
| 2016-02-29 | $0.03B | $0.00B | 17.14 |
| 2015-11-30 | $0.02B | $0.00B | 11.65 |
| 2015-08-31 | $0.02B | $0.00B | 11.67 |
| 2015-05-31 | $0.02B | $0.00B | 22.62 |
| 2015-02-28 | $0.02B | $0.00B | 30.24 |
| 2014-11-30 | $0.03B | $0.00B | 29.67 |
| 2014-08-31 | $0.02B | $0.00B | 22.38 |
| 2014-05-31 | $0.02B | $0.00B | 32.26 |
| 2014-02-28 | $0.02B | $0.00B | 67.72 |
| 2013-11-30 | $0.01B | $0.00B | 11.95 |
| 2013-08-31 | $0.01B | $0.00B | 17.35 |
| 2013-05-31 | $0.01B | $0.00B | 10.82 |
| 2013-02-28 | $0.01B | $0.00B | 12.65 |
| 2012-12-31 | $0.00B | 0.00 | |
| 2012-11-30 | $0.01B | $0.00B | 20.35 |
| 2012-08-31 | $0.01B | $0.00B | 8.19 |
| 2012-05-31 | $0.00B | $0.00B | 6.91 |
| 2012-02-29 | $0.00B | $0.00B | 5.34 |
| 2011-11-30 | $0.00B | $0.00B | 9.11 |
| 2011-09-30 | $0.00B | 0.00 | |
| 2011-08-31 | $0.00B | $0.00B | 9.71 |
| 2011-06-30 | $0.00B | 0.00 | |
| 2011-05-31 | $0.00B | 0.00 | |
| 2011-03-31 | $0.00B | 0.00 | |
| 2011-02-28 | $0.00B | 0.00 | |
| 2010-12-31 | $0.00B | 0.00 | |
| 2010-11-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.090B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $223.673B | 26.90 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.454B | 30.83 |
| EssilorLuxottica (ESLOY) | France | $127.910B | 0.00 |
| Medtronic (MDT) | Ireland | $108.054B | 15.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.940B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.883B | 26.67 |
| ResMed (RMD) | United States | $36.216B | 27.20 |
| GE HealthCare Technologies (GEHC) | United States | $33.352B | 15.84 |
| Agilent Technologies (A) | United States | $31.795B | 21.00 |
| Terumo (TRUMY) | Japan | $28.308B | 36.77 |
| Insulet (PODD) | United States | $22.619B | 88.79 |
| Koninklijke Philips (PHG) | Netherlands | $22.446B | 16.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.861B | 12.11 |
| Baxter (BAX) | United States | $15.559B | 11.62 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.250B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.641B | 22.45 |
| Lantheus Holdings (LNTH) | United States | $5.453B | 13.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.220B | 18.85 |
| Perrigo (PRGO) | Ireland | $3.576B | 9.06 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.449B | 15.02 |
| ICU Medical (ICUI) | United States | $3.346B | 24.67 |
| Envista Holdings (NVST) | United States | $3.039B | 25.25 |
| QuidelOrtho (QDEL) | United States | $2.269B | 15.60 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.92 |
| AtriCure (ATRC) | United States | $1.597B | 0.00 |
| Neogen (NEOG) | United States | $1.385B | 17.72 |
| AdaptHealth (AHCO) | United States | $1.200B | 12.19 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.150B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.047B | 0.00 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.946B | 12.10 |
| Evolus (EOLS) | United States | $0.644B | 0.00 |
| CeriBell (CBLL) | United States | $0.595B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.585B | 0.00 |
| Owens & Minor (OMI) | United States | $0.541B | 4.49 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.444B | 0.00 |
| Surmodics (SRDX) | United States | $0.399B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.350B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.341B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.307B | 11.29 |
| Sanuwave Health (SNWV) | United States | $0.293B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.283B | 50.40 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Verano Holdings (VRNOF) | United States | $0.261B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.259B | 0.00 |
| ZimVie (ZIMV) | United States | $0.243B | 11.04 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| Biote (BTMD) | United States | $0.216B | 6.06 |
| Brainsway (BWAY) | Israel | $0.194B | 51.35 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.38 |
| Quanterix (QTRX) | United States | $0.166B | 0.00 |
| Organigram Global (OGI) | Canada | $0.163B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.139B | 17.18 |
| Exagen (XGN) | United States | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.118B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.64 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.84 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |